WOLVERINE ASSET MANAGEMENT LLC - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V116. A total of 13 filers reported holding EFFECTOR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,418
-38.9%
18,662
+39.6%
0.00%
Q2 2023$2,320
+24.6%
13,372
-7.3%
0.00%
Q1 2023$1,862
-26.8%
14,418
-7.2%
0.00%
Q4 2022$2,544
+27.2%
15,545
+25.8%
0.00%
Q3 2022$2,000
-50.0%
12,355
-32.2%
0.00%
Q2 2022$4,000
-71.4%
18,229
-46.8%
0.00%
Q1 2022$14,000
-66.7%
34,296
-29.7%
0.00%
Q4 2021$42,000
-54.8%
48,772
-16.3%
0.00%
-100.0%
Q3 2021$93,00058,2410.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ARISTEIA CAPITAL, L.L.C. 1,493,292$161,2760.00%
MMCAP International Inc. SPC 145,941$11,0920.00%
LITTLEJOHN & CO LLC 16,666$1,2670.00%
Sea Otter Advisors LLC 25,000$1,9000.00%
WHITEBOX ADVISORS LLC 298,145$22,6590.00%
III Capital Management 41,795$4,5130.00%
Tower Research Capital LLC (TRC) 23$20.00%
Parallel Advisors, LLC 64,166$4,8770.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 56,083$4,2620.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders